The Gut-Immune-Brain Axis in Autism Spectrum Disorders; A Focus on Amino Acids
Open Access
- 16 April 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 10, 247
Abstract
Autism spectrum disorder (ASD) is a range of neurodevelopmental conditions that affect communication and social behavior. Besides social deficits, systemic inflammation, gastrointestinal immune-related problems, and changes in the gut microbiota composition are characteristic for people with ASD. Animal models showed that these characteristics can induce ASD-associated behavior, suggesting an intimate relationship between the microbiota, gut, immune system and the brain in ASD. Multiple factors can contribute to the development of ASD, but mutations leading to enhanced activation of the mammalian target of rapamycin (mTOR) are reported frequently. Hyperactivation of mTOR leads to deficits in the communication between neurons in the brain and to immune impairments. Hence, mTOR might be a critical factor linking the gut-brain-immune axis in ASD. Pharmacological inhibition of mTOR is shown to improve ASD-associated behavior and immune functions, however, the clinical use is limited due to severe side reactions. Interestingly, studies have shown that mTOR activation can also be modified by nutritional stimuli, in particular by amino acids. Moreover, specific amino acids are demonstrated to inhibit inflammation, improve gut barrier function and to modify the microbiota composition. In this review we will discuss the gut-brain-immune axis in ASD and explore the potential of amino acids as a treatment option for ASD, either via modification of mTOR activity, the immune system or the gut microbiota composition.Keywords
This publication has 188 references indexed in Scilit:
- Elevated Fecal Short Chain Fatty Acid and Ammonia Concentrations in Children with Autism Spectrum DisorderDigestive Diseases and Sciences, 2012
- The role of immune dysfunction in the pathophysiology of autismBrain, Behavior, and Immunity, 2012
- Inflammation-Related Disorders in the Tryptophan Catabolite Pathway in Depression and Somatization2012
- Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disordersJournal of Neuroimmunology, 2011
- Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcomeBrain, Behavior, and Immunity, 2011
- Pyrosequencing study of fecal microflora of autistic and control childrenAnaerobe, 2010
- Mammalian Target of Rapamycin Protein Complex 2 Regulates Differentiation of Th1 and Th2 Cell Subsets via Distinct Signaling PathwaysImmunity, 2010
- The mTOR Kinase Differentially Regulates Effector and Regulatory T Cell Lineage CommitmentImmunity, 2009
- Decreased transforming growth factor beta1 in autism: A potential link between immune dysregulation and impairment in clinical behavioral outcomesJournal of Neuroimmunology, 2008
- The critical contribution of TGF‐β to the induction of Foxp3 expression and regulatory T cell functionEuropean Journal of Immunology, 2008